Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Kinetics of SARS-CoV-2 antibody responses pre- and post- COVID-19 convalescent plasma transfusion in patients with severe respiratory failure: an observational case-control study

Matthew N. Klein, Elizabeth Wenqian Wang, Paul Zimand, Heather Beauchamp, Caitlin Donis, View ORCID ProfileMatthew D. Ward, Aidaelis Martinez-Hernandez, Ali Tabatabai, John W. Baddley, Evan M. Bloch, Kristin E. Mullins, Magali J. Fontaine
doi: https://doi.org/10.1101/2020.12.10.20247007
Matthew N. Klein
1Department of Pathology, University of Maryland School of Medicine, Baltimore MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Wenqian Wang
2University of Maryland Saint Joseph Medical Center, Baltimore MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Zimand
3University of Maryland Medical System, Baltimore MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather Beauchamp
4University of Maryland Upper Chesapeake Medical Center, Bel Air MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caitlin Donis
4University of Maryland Upper Chesapeake Medical Center, Bel Air MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew D. Ward
1Department of Pathology, University of Maryland School of Medicine, Baltimore MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew D. Ward
Aidaelis Martinez-Hernandez
1Department of Pathology, University of Maryland School of Medicine, Baltimore MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ali Tabatabai
5Department of Medicine, University of Maryland School of Medicine, Baltimore MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John W. Baddley
5Department of Medicine, University of Maryland School of Medicine, Baltimore MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evan M. Bloch
6Department of Pathology, School of medicine, Johns Hopkins University, Baltimore, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristin E. Mullins
1Department of Pathology, University of Maryland School of Medicine, Baltimore MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magali J. Fontaine
1Department of Pathology, University of Maryland School of Medicine, Baltimore MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mfontaine@som.umaryland.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

OBJECTIVES To investigate if COVID-19 convalescent plasma (CCP) transfusion in patients with severe respiratory failure will increase plasma levels of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibody titers while improving survival and clinical outcomes.

DESIGN Observational, retrospective, control study of anti-Receptor binding domain (RBD) of SARS-CoV-2 IgG and IgM titers from serial plasma samples drawn before and after CCP administration. Clinical improvement in CCP recipients is assessed and compared to COVID-19 control patients.

SETTING Patients hospitalized with severe COVID19, United States, between April 17 and July 19, 2020

PARTICIPANTS 34 patients hospitalized with severe or life threatening COVID-19 and who consented and received a CCP transfusion, 95 control patients with COVID-19 not transfused with CCP. 34 out the 95 control patients were matched for age, sex, and the level of respiratory support required. Patients less than 18 years old were excluded.

MAIN OUTCOME MEASURES Serial trends of anti-RBD of SARS-CoV-2 IgG and IgM titers in CCP recipients are compared to those in control patients. The primary outcome is survival at 30 days, and the secondary outcomes are length of ventilatory and/or extracorporeal membrane oxygenation (ECMO) support, length of stay (LOS) in the hospital, and LOS in the ICU.

RESULTS CCP transfusion occurred in 34 patients at a median of 12 days following COVID-19 symptom onset. Immediately prior to CCP transfusion, patients median anti-RBD SARS-CoV-2 IgG and IgM titers were 1:3200 (IQR, 1:50 to 1:9600) and 1:320 (IQR, 1:40 to 1:640) respectively. Following a Loess regression analysis, the kinetics and distribution of anti-RBD of SARS-CoV-2 IgG and IgM in plasma from CCP recipients were comparable to those from a control group of 68 patients who did not receive CCP. CCP recipients presented with similar survival, similar duration on ventilatory and/or ECMO support, as well as ICU and hospital LOS, compared to a matched control group of 34 patients.

CONCLUSION In the present study, hospitalized COVID-19 patients with severe respiratory failure transfused with CCP presented with high titers of SARS-CoV-2 IgG antibodies before transfusion and did not show improved survival at 30 days.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

Observational study

Funding Statement

This study was funded by the University of Maryland School of Medicine Department of Pathology Funds and by the Biomedical Advanced Research and Development Authority (BARDA).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the University of Maryland Baltimore Institutional Research Subject Review Board (Protocol HP-00092606). The investigators have followed all appropriate research reporting guidelines.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • co-authors titles and contact: Mr. Matthew Klein, Research assistant, mnklein{at}som.umaryland.edu

    Dr. Elizabeth Wang, Infectious disease physician, Elizabeth.wang{at}umm.edu

    Mr. Paul Zimand, Data Scientist, paulzimand{at}umm.edu

    Ms. Heather Beauchamp, Research coordinator, hbeauchamp{at}umm.edu

    Ms. Caitlin Donis, Research coordinator, cdonis{at}umm.edu

    Dr. Matthew Ward, Post-doctoral fellow, mdward{at}som.umaryland.edu

    Ms. Aidaelis Martinez-Hernandez, Post-baccalaureate research fellow, aidaelis.martinez{at}som.umaryland.edu

    Dr. Ali Tabatabai, Critical care physician, atabatabai{at}som.umaryland.edu

    Dr. John Baddley, Infectious disease physician, Jbaddley{at}ihv.umaryland.edu

    Dr. Evan M. Bloch, Transfusion medicine physician, ebloch2{at}jhmi.edu

    Dr. Kristin E. Mullins, Associate Director of CORE laboratories, kmullins{at}som.umaryland.edu

Data Availability

Upon request Data sources can be provided for results presented in the study

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted December 11, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Kinetics of SARS-CoV-2 antibody responses pre- and post- COVID-19 convalescent plasma transfusion in patients with severe respiratory failure: an observational case-control study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Kinetics of SARS-CoV-2 antibody responses pre- and post- COVID-19 convalescent plasma transfusion in patients with severe respiratory failure: an observational case-control study
Matthew N. Klein, Elizabeth Wenqian Wang, Paul Zimand, Heather Beauchamp, Caitlin Donis, Matthew D. Ward, Aidaelis Martinez-Hernandez, Ali Tabatabai, John W. Baddley, Evan M. Bloch, Kristin E. Mullins, Magali J. Fontaine
medRxiv 2020.12.10.20247007; doi: https://doi.org/10.1101/2020.12.10.20247007
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Kinetics of SARS-CoV-2 antibody responses pre- and post- COVID-19 convalescent plasma transfusion in patients with severe respiratory failure: an observational case-control study
Matthew N. Klein, Elizabeth Wenqian Wang, Paul Zimand, Heather Beauchamp, Caitlin Donis, Matthew D. Ward, Aidaelis Martinez-Hernandez, Ali Tabatabai, John W. Baddley, Evan M. Bloch, Kristin E. Mullins, Magali J. Fontaine
medRxiv 2020.12.10.20247007; doi: https://doi.org/10.1101/2020.12.10.20247007

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pathology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (46)
  • Cardiovascular Medicine (415)
  • Dentistry and Oral Medicine (70)
  • Dermatology (47)
  • Emergency Medicine (144)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4855)
  • Forensic Medicine (3)
  • Gastroenterology (183)
  • Genetic and Genomic Medicine (676)
  • Geriatric Medicine (70)
  • Health Economics (192)
  • Health Informatics (629)
  • Health Policy (320)
  • Health Systems and Quality Improvement (203)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5339)
  • Intensive Care and Critical Care Medicine (330)
  • Medical Education (93)
  • Medical Ethics (24)
  • Nephrology (75)
  • Neurology (686)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (208)
  • Oncology (439)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (89)
  • Pain Medicine (35)
  • Palliative Medicine (16)
  • Pathology (129)
  • Pediatrics (194)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (780)
  • Public and Global Health (1816)
  • Radiology and Imaging (324)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (62)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)